Lidocaine Hydrochloride
LIDO CAINE HYDROCHLORIDE INJECTION, USP
Approved
Approval ID
1631e5ca-03d0-4d3b-91e3-2dc14f4eb0e1
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Mar 11, 2020
Manufacturers
FDA
Hikma Pharmaceuticals USA Inc.
DUNS: 001230762
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Lidocaine Hydrochloride
PRODUCT DETAILS
NDC Product Code0143-9594
Application NumberANDA084625
Marketing CategoryC73584
Route of AdministrationEPIDURAL, INFILTRATION, INTRACAUDAL
Effective DateSeptember 17, 2018
Generic NameLidocaine Hydrochloride
INGREDIENTS (4)
LIDOCAINE HYDROCHLORIDEActive
Quantity: 20 mg in 1 mL
Code: V13007Z41A
Classification: ACTIR
SODIUM CHLORIDEInactive
Quantity: 6 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
LIDOCAINE HYDROCHLORIDE
PRODUCT DETAILS
NDC Product Code0143-9595
Application NumberANDA084625
Marketing CategoryC73584
Route of AdministrationEPIDURAL, INFILTRATION, INTRACAUDAL
Effective DateSeptember 17, 2018
Generic NameLIDOCAINE HYDROCHLORIDE
INGREDIENTS (4)
LIDOCAINE HYDROCHLORIDEActive
Quantity: 10 mg in 1 mL
Code: V13007Z41A
Classification: ACTIR
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
SODIUM CHLORIDEInactive
Quantity: 7 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT